Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Magnetic Resonance Imaging | Case report

Late metachronous cerebral metastasis of pancreatic adenocarcinoma of the tail of the pancreas: a case report

Authors: Kyriakos Papadimitriou, Daniel Kiss-Bodolay, Abderrahmane Hedjoudje, Diego San Millan, Alexandre Simonin, Jean-Yves Fournier, Karen Huscher

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Pancreatic cancer is one of the leading causes of cancer mortality and one of the most lethal malignant neoplasms worldwide. It is known for its local tumor extension to the liver; other common sites include the lung, distant lymph nodes, and bone. Brain metastases are extremely rare and represent less than 0.6% of all brain metastases.

Case report

We report the case of a 66-year-old Caucasian female known to have adenocarcinoma of the tail of the pancreas treated with chemotherapy. During follow-up, thoracoabdominal computed tomography scans did not reveal any residual tumor or any metastasis. Moreover, tumor markers were within normal limits. She presented to the emergency department of our institution following an episode of a generalized tonic–clonic seizure 5 years following the initial diagnosis. Brain magnetic resonance imaging revealed an expansive left frontal intraaxial lesion compatible with high-grade glioma. The patient underwent surgical treatment. Histological examination revealed pancreatic metastasis.

Conclusions

Thought to be rare, metachronous cerebral pancreatic metastasis should be kept in mind in patients with pancreatic cancer. Early diagnosis and complete surgical resection play a key role in the survival of these patients.
Literature
1.
go back to reference Arao Y, et al. Rare brain metastasis from a pancreatobiliary subtype of intraductal papillary mucinous neoplasm. Pancreas. 2020;49(1):e8–11.CrossRef Arao Y, et al. Rare brain metastasis from a pancreatobiliary subtype of intraductal papillary mucinous neoplasm. Pancreas. 2020;49(1):e8–11.CrossRef
2.
go back to reference Artinyan A, et al. The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB (Oxford). 2008;10(5):371–6.CrossRef Artinyan A, et al. The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB (Oxford). 2008;10(5):371–6.CrossRef
3.
go back to reference Ferreira Filho AF, et al. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma. Ann Oncol. 2001;12(12):1757–9.CrossRef Ferreira Filho AF, et al. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma. Ann Oncol. 2001;12(12):1757–9.CrossRef
4.
go back to reference Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694–705.CrossRef Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694–705.CrossRef
5.
go back to reference Kumar A, et al. CNS involvement in pancreatic adenocarcinoma: a report of eight cases from the Johns Hopkins Hospital and review of literature. J Gastrointest Cancer. 2015;46(1):5–8.CrossRef Kumar A, et al. CNS involvement in pancreatic adenocarcinoma: a report of eight cases from the Johns Hopkins Hospital and review of literature. J Gastrointest Cancer. 2015;46(1):5–8.CrossRef
6.
go back to reference Kuratsu J, et al. Brain and skull metastases of hepatic or pancreatic cancer–report of six cases. Neurol Med Chir (Tokyo). 1990;30(7):476–82.CrossRef Kuratsu J, et al. Brain and skull metastases of hepatic or pancreatic cancer–report of six cases. Neurol Med Chir (Tokyo). 1990;30(7):476–82.CrossRef
7.
go back to reference Kuroda N, et al. Cerebellar metastasis of unknown primary neuroendocrine carcinoma: report of case mimicking hemangioblastoma. World Neurosurg. 2019;128:320–3.CrossRef Kuroda N, et al. Cerebellar metastasis of unknown primary neuroendocrine carcinoma: report of case mimicking hemangioblastoma. World Neurosurg. 2019;128:320–3.CrossRef
8.
go back to reference Lee YT, Tatter D. Carcinoma of the pancreas and periampullary structures. Pattern of metastasis at autopsy. Arch Pathol Lab Med. 1984;108(7):584–7.PubMed Lee YT, Tatter D. Carcinoma of the pancreas and periampullary structures. Pattern of metastasis at autopsy. Arch Pathol Lab Med. 1984;108(7):584–7.PubMed
9.
go back to reference Lemke J, et al. Long-term survival following resection of brain metastases from pancreatic cancer. Anticancer Res. 2011;31(12):4599–603.PubMed Lemke J, et al. Long-term survival following resection of brain metastases from pancreatic cancer. Anticancer Res. 2011;31(12):4599–603.PubMed
10.
go back to reference Lemke J, et al. Brain metastasis in pancreatic cancer. Int J Mol Sci. 2013;14(2):4163–73.CrossRef Lemke J, et al. Brain metastasis in pancreatic cancer. Int J Mol Sci. 2013;14(2):4163–73.CrossRef
11.
go back to reference Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20(2):197–209.CrossRef Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20(2):197–209.CrossRef
12.
go back to reference Luu AM, et al. Prognostic value and impact of cerebral metastases in pancreatic cancer. Acta Chir Belg. 2020;120(1):30–4.CrossRef Luu AM, et al. Prognostic value and impact of cerebral metastases in pancreatic cancer. Acta Chir Belg. 2020;120(1):30–4.CrossRef
13.
go back to reference Marepaily R, et al. Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course. Dig Dis Sci. 2009;54(1):188–90.CrossRef Marepaily R, et al. Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course. Dig Dis Sci. 2009;54(1):188–90.CrossRef
14.
go back to reference Matsumoto H, Yoshida Y. Brain metastasis from pancreatic cancer: a case report and literature review. Asian J Neurosurg. 2015;10(1):35–9.CrossRef Matsumoto H, Yoshida Y. Brain metastasis from pancreatic cancer: a case report and literature review. Asian J Neurosurg. 2015;10(1):35–9.CrossRef
15.
go back to reference Moore MJ, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25(15):1960–6.CrossRef Moore MJ, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25(15):1960–6.CrossRef
16.
go back to reference Naugler C, Xu Z. Pancreatic adenocarcinoma metastatic to the pineal gland. J Clin Neurosci. 2008;15(11):1284–6.CrossRef Naugler C, Xu Z. Pancreatic adenocarcinoma metastatic to the pineal gland. J Clin Neurosci. 2008;15(11):1284–6.CrossRef
17.
go back to reference Ng JY et al. Metastatic pancreatic adenocarcinoma presenting as an occipital haemorrhage. BMJ Case Rep 2018; 2018. Ng JY et al. Metastatic pancreatic adenocarcinoma presenting as an occipital haemorrhage. BMJ Case Rep 2018; 2018.
18.
go back to reference Oweira H, et al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a surveillance epidemiology and end results database analysis. World J Gastroenterol. 2017;23(10):1872–80.CrossRef Oweira H, et al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a surveillance epidemiology and end results database analysis. World J Gastroenterol. 2017;23(10):1872–80.CrossRef
19.
go back to reference Park KS, et al. Nervous system involvement by pancreatic cancer. J Neurooncol. 2003;63(3):313–6.CrossRef Park KS, et al. Nervous system involvement by pancreatic cancer. J Neurooncol. 2003;63(3):313–6.CrossRef
20.
go back to reference Peixoto RD, et al. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. Cancer Med. 2015;4(8):1171–7.CrossRef Peixoto RD, et al. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. Cancer Med. 2015;4(8):1171–7.CrossRef
21.
go back to reference Rao R, et al. An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis. Gastrointest Cancer Res. 2013;6(3):90–2.PubMedPubMedCentral Rao R, et al. An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis. Gastrointest Cancer Res. 2013;6(3):90–2.PubMedPubMedCentral
22.
go back to reference Sasaki T, et al. Brain metastasis in pancreatic cancer: two case reports. Medicine (Baltimore). 2019;98(4):e14227.CrossRef Sasaki T, et al. Brain metastasis in pancreatic cancer: two case reports. Medicine (Baltimore). 2019;98(4):e14227.CrossRef
23.
go back to reference Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.CrossRef Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.CrossRef
24.
go back to reference Soffietti R, et al. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol. 2017;19(2):162–74.CrossRef Soffietti R, et al. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol. 2017;19(2):162–74.CrossRef
25.
go back to reference Szerlip NJ, et al. Pancreatoblastoma metastases to the brain. Case illustration. J Neurosurg. 2007;106(2 Suppl):169.PubMed Szerlip NJ, et al. Pancreatoblastoma metastases to the brain. Case illustration. J Neurosurg. 2007;106(2 Suppl):169.PubMed
26.
go back to reference Tomasello G, et al. Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies. J Gastrointest Oncol. 2019;10(2):259–69.CrossRef Tomasello G, et al. Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies. J Gastrointest Oncol. 2019;10(2):259–69.CrossRef
27.
go back to reference Voutsadakis IA, et al. Bone and brain metastases from ampullary adenocarcinoma. World J Gastroenterol. 2009;15(21):2665–8.CrossRef Voutsadakis IA, et al. Bone and brain metastases from ampullary adenocarcinoma. World J Gastroenterol. 2009;15(21):2665–8.CrossRef
28.
go back to reference Whipple AO. A reminiscence: pancreaticduodenectomy. Rev Surg. 1963;20:221–5.PubMed Whipple AO. A reminiscence: pancreaticduodenectomy. Rev Surg. 1963;20:221–5.PubMed
29.
go back to reference Yang S, Zhang H, Ren X. The application of high-field magnetic resonance perfusion imaging in the diagnosis of pancreatic cancer. Medicine (Baltimore). 2017;96(36):e7571.CrossRef Yang S, Zhang H, Ren X. The application of high-field magnetic resonance perfusion imaging in the diagnosis of pancreatic cancer. Medicine (Baltimore). 2017;96(36):e7571.CrossRef
Metadata
Title
Late metachronous cerebral metastasis of pancreatic adenocarcinoma of the tail of the pancreas: a case report
Authors
Kyriakos Papadimitriou
Daniel Kiss-Bodolay
Abderrahmane Hedjoudje
Diego San Millan
Alexandre Simonin
Jean-Yves Fournier
Karen Huscher
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03314-w

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue